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GATA6s in identifying signaling molecules that induce cardiogenesis in mammals, the
transcription factors that control the onset of cardiac myocyte gene expression have remained elusive.
Candidates include the zinc ﬁnger transcription factors GATA binding proteins 4 and 6 (GATA4, GATA6). The
individual loss of either protein in mice results in lethality prior to the onset of heart development due to
defects in the extra-embryonic endoderm; however, when this extra-embryonic deﬁciency is circumvented
using tetraploid embryo complementation, cardiac myocyte differentiation initiates normally. Here we show
that these factors have redundant roles in controlling the onset of cardiac myocyte differentiation. As a
consequence, Gata4−/−Gata6−/− embryos completely lack hearts, although second heart ﬁeld progenitor cells
are still generated. Our data support a model whereby GATA4 or GATA6 are essential for expression of the
network of transcription factors that regulate the onset of cardiac myocyte gene expression during
mammalian development.
© 2008 Elsevier Inc. All rights reserved.Introduction
Studies in Drosophila melanogaster, Danio rerio and Xenopus laevis
have implicated several families of transcription factors in initiating
cardiac myocyte gene expression in response to inductive signals, in-
cluding the Nkx, Tbx, Mef, and GATA families as well as SRF (Olson and
Schneider, 2003). However, no single mutation has been identiﬁed
that blocks cardiac myocyte differentiation in mammals, suggesting
that functional redundancy between factors exists. The GATA binding
proteins are zinc ﬁnger transcription factors that have been implicated
in regulating the onset of cardiac myocyte differentiation (Pikkarainen
et al., 2004). GATA4, 5 and 6 are all expressed in cardiac progenitor
cells, and all three proteins, although individually dispensable for
cardiac myocyte formation, have critical roles in regulating heart
development in zebraﬁsh and frogs (Holtzinger and Evans, 2005;
Peterkin et al., 2003; Reiter et al., 1999). More recently, morpholino-
mediated depletion of combinations of GATA factors has resulted in
preventing aspects of cardiac speciﬁcation in Zebraﬁsh and Xenopus
suggesting that the GATA factors have redundant but essential roles in
controlling early stages of heart development in these species
(Holtzinger and Evans, 2007; Peterkin et al., 2007). Elucidating the
contribution the GATA factors make to the development of the mam-
malian heart has been challenging. Gene knockout studies in mice
demonstrated that GATA5 was dispensable for embryonic develop-l rights reserved.ment (Molkentin et al., 2000), while loss of either GATA4 or GATA6
resulted in a developmental arrest during gastrulation due to a re-
quirement for these factors in the extra-embryonic endoderm (Kout-
sourakis et al., 1999; Kuo et al., 1997; Molkentin et al., 1997; Morrisey
et al., 1998). When this early embryonic lethality was circumvented by
providing GATA4 or GATA6 null embryos with wild type extra-em-
bryonic endoderm, formation of the early heart and cardiac myocyte
gene expression appeared relatively normal, although subtle deﬁ-
ciencies in maturation of the myocytes were identiﬁed (Narita et al.,
1997b; Watt et al., 2004; Zhao et al., 2005). GATA4 and GATA6 are
highly conserved, are capable of binding identical nucleotide
sequences in genomic DNA, and regulate expression of similar target
genes (Morrisey et al., 1997; Nemer and Nemer, 2003; Pikkarainen
et al., 2004). We therefore sought to test the proposal that these
factors had redundant functions in controlling mammalian cardiac
myocyte differentiation and predicted that if both factors were simul-
taneously disrupted, the onset of cardiac development would be
blocked.
Materials and methods
Generation of Gata4−/−Gata6−/− ES cell lines, embryoid bodies and embryos
The production of Gata4−/− and Gata6−/− ES cells have been described previously
(Watt et al., 2004; Zhao et al., 2005). To generate Gata4−/−Gata6−/− ES cells, we ﬁrst
produced a targeting vector, pGATA4loxPDT, that contains a Neo-tk cassette ﬂanked by
two loxP sites (sites a and b) from plasmid pHR-1 that was inserted into the SmaI site
85 bp upstream of Gata4 exon 3 (Watt et al., 2004). In addition, a single loxP site (site c)
from plasmid pHR-1 was inserted into the BamHI site between exons 5 and 6. Negative
selection was provided by the diptheria toxin gene. Cre mediated recombination
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activation domain of GATA4 resulting in complete loss of function and the absence of
detectable protein (Watt et al., 2004). We generated a 3′probe, used for Southern blot
analysis, by PCR from genomic DNA using the primers g4-192 5′ ATGAAAACAGCTTCC-
CACCC 3′ and g4-193 5′ AGACTGGCCCTAAGCTATTG 3′. This probe is located between
exon 6 and the downstream SacI and EcoRI sites and identiﬁes 11 kb SacI (not shown)
and 3 kb EcoRI wild type Gata4 DNA fragments (Figs. 1a, c). R1 ES cells were electro-
poratedwith the pGATA4loxPDT vector and grown in 350 μg/ml G418 for 7 days to select
for transformants. Homologous recombination was predicted to produce the Gata4
loxPNeo allele that generated a unique 5 kb SacI fragment due to the addition of a SacI
site within Neo-tk and a unique 2 kb EcoRI fragment due to the addition of an EcoRI site
in loxPc (Watt et al., 2004). We electroporated Gata4+/loxPneo ES cells with a Cre ex-
pression plasmid, pHDMCCre8, grew the cells for 3 days without selection, and then
cultured in 2 μM gancyclovir for 5 days to select for deletion of the Neo-tk cassette.
Deletion of the Neo-tk cassette could occur by recombination between loxPa and loxPb
(see Fig. 1 of Watt et al., 2004), deleting only the Neo-tk cassette and leaving behind a
single loxPa/b site and the loxPc site ﬂanking exons 3–5. This produces the Gata4 loxP
allele with an 11 kb SacI fragment and a 2 kb EcoRI fragment. Alternatively, recom-
bination between loxP a and loxP c deletes the neo-tk cassette and 2 kb of genomic DNA
leaving behind a single loxP a/c site. This produces a Gata4− allele with a 9 kb SacI
fragment (not shown) and a 2 kb EcoRI fragment (Figs. 1a, c) (Watt et al., 2004). Gata4−/−
ES cells were generated by targeting Gata4+/− ES cells with same targeting vector
followed by transient expression of Cre as described above. We conﬁrmed the genotype
of Gata4−/− ES cells by Southern blot (Fig. 1c) and loss of GATA4 expression by RT-PCR
analyses of embryoid bodies (Fig. 1e) and immunohistochemistry on Gata4−/− ES cell–
derived embryos (Watt et al., 2004).We next targeted the Gata6 gene in Gata4−/− ES cells
using the targeting vector described byMorrisey et al. (1998) and used by us previously
to generate Gata6−/− ES cells (Zhao et al., 2005). This vector contains a Pgk–Neo cassette,Fig.1. Loss of both GATA4 and GATA6 disrupts cardiacmyocyte gene expression in ES cell emb
ES cells. Genomic structure of wild type (WT) andmutated (MUT) GATA4 (a) and GATA6 (b) al
cassette as a shaded box. Position of Southern blot probes and sizes of relevant genomic DNA
conﬁrming the genotype of ES cell lines with DNA fragment sizes shown in kb. (d) Graph
experimental Gata4−/−Gata6+/+, Gata4+/+ Gata6−/−, Gata4−/−Gata6+/−, Gata4−/−Gata6−/− (clones 1
steady-state cardiac mRNA levels in control and GATA knockout embryoid bodies. Polr2a; R
heavy chain,Myh7;cardiac beta myosin heavy chain,Myl2;cardiac myosin light chain 2v,Myl7;m
PCR analyses, in abundance of mRNAs encoding cardiac transcription factors.which replaces exons encoding both zinc ﬁngers and results in a Gata6 null allele
(Morrisey et al., 1998). We electroporated Gata4−/− ES cells with the targeting vector and
collected colonies that were resistant to growth in G418 (350 μg/ml). We next identiﬁed
Gata6+/− ES cells by genomic Southern blot analyses using a probe that ﬂanks exon 5 and
identiﬁes a 13 kb wild type Gata6 BamHI fragment and an 8 kb BamHI fragment in the
targeted allele (Figs. 1b,c). We next cultured Gata4−/−Gata6+/− ES cells in culture medium
supplemented with an elevated concentration (1.5 mg/ml) of G418, as described (Zhao
et al., 2005), and identiﬁed Gata4−/−Gata6−/− ES cells by Southern blot analyses (Fig. 1c).
We produced embryoid bodies after treating ES cells with Noggin and withdrawing
leukemia inhibitory factor following the procedure described by Yuasa et al. (2005).
Embryoid bodies were collected at day 9 after removal of LIF from three independent
experiments. We produced embryos directly from ES cells by tetraploid embryo
complementation as described elsewhere (Nagy and Rossant, 1993) and considered
noon on the day we identiﬁed a vaginal plug in surrogate mothers as E0.5.
Oligonucleotide arrays, RT-PCR and real-time qRT-PCR
We collected total RNA from three independent control and Gata4−/−Gata6−/− em-
bryoid body preparations using an RNeasy puriﬁcation kit (Qiagen). Probes were
prepared following Affymetrix protocols. Each sample was hybridized to an individual
Affymetrix GeneChipMouse Genome 2.0 array and datawere analyzed using DCHIP Ver.
1.3 software. We carried out semi-quantitative RT-PCR as described previously (Zhao
et al., 2005). Real time quantitative RT-PCR was performed using SYBR green
incorporation with reactions run on a BioRad iCycler™ following the manufacturer’s
protocol using empirically optimized primer pairs. All oligonucleotide sequences are
available on request, with the exception of proprietary oligonucleotides purchased from
Superarray Bioscience Corp that were optimized for qRT-PCR ampliﬁcation of Mesp1
(cat#PPM24667A) or Mesp2 (cat# PPM27883A).ryoid bodies. (a, b) Schematic overview of the strategy used to generate Gata4−/−Gata6−/−
leles with exons presented as open boxes, the loxP site as a closed circle, and the Pgk-Neo
fragments following digestionwith EcoRI(E) or BamHI(B) are indicated. (c) Southern blot
showing percentage of contractile embryoid bodies generated from control (R1) and
and 2) ES cells in three independent experiments (error bars). (e) RT-PCR analysis of
NA Polymerase II, Actc1; cardiac alpha actin, Cnn1;Calponin, Myh6;cardiac alpha myosin
yosin light chain 2a. (f) Table showing changes, determined by real-time quantitative RT-
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We collected embryos, ﬁxed them with 4% paraformaldehyde, and stored them in
70% ethanol. We processed embryos for parafﬁn sections as described previously (Watt
et al., 2004; Zhao et al., 2005). We performed immunohistochemistry on either whole
embryos or sections following microwave antigen retrieval as we discussed elsewhere
(Watt et al., 2004; Zhao et al., 2005). We used the following primary antibodies: anti-
smooth muscle actin (Sigma A-2547; 1:800); MF20, anti-myosin heavy chain
(Developmental Hybridoma Bank; 1:1000), FoxA1 (C-20, Santa Cruz, sc-6553; 1:400),
sarcomeric actin (Sigma A-2172; 1:800), HNF4α (C-19, Santa Cruz, sc-6556; 1:500),
CD31/PECAM (CD31, BD Pharmingen#553370; 1:50).Wholemount in situ hybridization
was performed using digoxigenin–labeled probes generated by in vitro transcription
(Roche) following standard procedures.
Results
GATA4 and GATA6 are essential for differentiation of cardiac myocytes
from ES cells
To test the proposal that GATA4 and GATA6 had redundant yet
essential roles in controlling cardiacmyocyte differentiation, we gene-
rated Gata4−/−Gata6+/+ (Watt et al., 2004), Gata4+/+Gata6−/− (Zhao et al.,
2005),Gata4−/−Gata6+/−, andGata4−/−Gata6−/− ES cells by gene targeting
(Figs. 1a–c) (details of targeting are presented in the Materials and
methods section). ES cells of each genotypewere then induced to form
cardiac myocytes following the protocol described by Yuasa et al.
(2005), and the number of beating embryoid bodies, which presum-
ably reﬂects cardiacmyocyte differentiation, was determined by visual
inspection. As described previously (Yuasa et al., 2005) this protocol
resulted in the efﬁcient generation of beating cells fromwild typeR1 ES
cellswith beating observed in N80%of embryoid bodies (Fig.1d).When
either Gata4 or Gata6 was disrupted the number of beating embryoid
bodies was dramatically reduced, with only 10% of the embryoid
bodies containing contractile cells (Fig. 1d). This reduction in the
number of beating cells is similar to that previously reported for loss of
GATA4 in ES cell embryoid bodies and may reﬂect a loss of
extraembryonic endoderm necessary for maturation rather than a
cell autonomous effect (Narita et al., 1997a). No signiﬁcant difference
was observed in the number of beating embryoid bodies when cells
lacked either GATA4 or GATA6. However, if one allele of Gata6 was
disrupted in the Gata4−/− ES cells then the number of beating embryoid
bodies decreased further to 5% (Fig. 1d). Most notably, no beating cells
were identiﬁed in embryoid bodies lacking both GATA4 and GATA6
(Fig. 1d).
If the loss of beating cells reﬂects a failure in cardiac myocyte
differentiation we predicted that cardiac gene expression should be
disrupted in Gata4−/−;Gata6−/− embryoid bodies. RT-PCR was there-
fore performed on control (Gata4+/+ Gata6+/+), Gata4−/−, Gata6−/−,
Gata4−/−Gata6+/−, and Gata4−/−Gata6−/− embryoid bodies to determine
the abundance of a subset of mRNAs encoding proteins whose expres-
sion is characteristic of cardiac myocyte differentiation (Fig. 1e). These
included cardiac alpha actin, calponin, and alpha and beta myosin
heavy and light chains (encoded by Actc1, Cnn1, Myh6, Myh7, Myl2,
Myl7, respectively). Previous in vivo analyses had demonstrated that
loss of eitherGATA4orGATA6had relatively little impact on expression
of these key cardiac myocyte mRNAs (Watt et al., 2004; Zhao et al.,
2005). Consistent with these analyses and despite the observation that
contractility was reduced in both Gata4−/− and Gata6−/− embryoid
bodies, cardiac myocyte gene expression was unaffected by loss of
either GATA4 or GATA6 alone when compared with control embryoid
bodies (Fig. 1e). However, we measured a large reduction in the levels
of these cardiac myocyte mRNAs in embryoid bodies generated from
Gata4−/−Gata6+/− ES cells, and they were virtually undetectable in
embryoid bodies generated from Gata4−/−Gata6−/− ES cells (Fig. 1e).
These changes in cardiac mRNA levels were conﬁrmed by oligonucleo-
tide array analyses (not shown).
A complex network of cardiac transcription factors is believed to
deﬁne the differentiated state of cardiac myocytes (Olson and Schnei-der, 2003; Srivastava and Olson, 2000), and sowe next determined the
level of mRNAs encoding such transcription factors using qRT-PCR. Fig.
1f shows that the level of Nkx2.5, Tbx20, Tbx5, Mef2c, Gata5, Hand1,
and Hand2 mRNAs was substantially reduced in the absence of both
GATA4 and 6 compared towild type cells. Of note, however, the level of
Isl1, Mesp1, and Mesp2 mRNAs, which are characteristically expressed
in cardiac progenitor cells (Cai et al., 2003; Kitajima et al., 2000;
Moretti et al., 2006), was not reduced. Cumulatively, these data
conﬁrm that GATA4 and GATA6 have redundant functions in control-
ling cardiacmyocyte differentiation and furthermore suggest that they
are dispensable for formation of cardiac progenitor cells.
GATA4 and GATA6 are redundant but essential for cardiac development
in mouse embryos
The possibility of functional complementation requires that both
GATA factors be expressed during the onset of cardiac development in
overlapping cell compartments. We therefore performed in situ
hybridization analyses to detect Gata4 and Gata6 mRNAs in devel-
opmentally matched embryos. Fig. 2a shows that both Gata4 and
Gata6 mRNAs could be detected in overlapping patterns in cardiac
progenitor cells that are present in the cardiac crescent at E7.5 (early
headfold stage), as well as in the nascent heart tube, cardiac outﬂow
and inﬂow tracts at E8.5 (6–8 somites), which is consistent with pre-
vious reports (Dodou et al., 2004; Morrisey et al., 1996; Waldo et al.,
2001). We next compared development of the heart in embryos gene-
rated from either control or Gata4−/−Gata6−/− ES cells by tetraploid
embryo complementation in order to deﬁnitively establish whether
these factors were essential for cardiac myocyte differentiation in
vivo. Fig. 2b shows that by E8.5 control wild type ES cell–derived
embryos had formed a distinctive heart tube that protruded from
the ventral face of the embryo (arrowhead). In contrast, the heart
appeared to be completely absent from embryos (nN97) generated
from Gata4−/−Gata6−/− ES cells (Fig. 2b). Acardia was found to occur in
embryos generated from three independently targeted Gata4−/−Gata6−/−
ES cell lines and was 100% penetrant. The absence of the heart in
GATA4/6 null embryos did not appear to be a consequence of a general
embryonic arrest or a defect in gastrulation because histological sec-
tions revealed that Gata4−/−Gata6−/− embryos retained many features
characteristic of this developmental stage (Fig. 2c). This included the
generation of the expected number of somite pairs (8–12 somite pairs
per embryo), the formation of a headfold and the development of the
neural tube (Fig. 2c, H&E). The presence of condensed somitic meso-
derm conﬁrmed that formation, migration and patterning of the
paraxial mesodermwas intact (Fig. 2c, H&E). In addition, the presence
of deﬁnitive endoderm lining the entire ventral aspect of both control
and experimental embryos was conﬁrmed using immunohistochem-
istry to detect FoxA1 (Fig. 2c, FoxA1) and in situ hybridization to detect
FoxA2 (Fig. 2c, FoxA2), although it was noted that morphogenesis of
the foregut was deﬁcient in the mutant embryos. The possibility that
the FoxA1/A2 expressing endodermwas in fact extra embryonic endo-
derm was excluded because this endoderm failed to express HNF4α
(Fig. 2c, HNF4), which is present exclusively in the extra embryonic
endoderm at this developmental stage (Duncan et al., 1994; Taraviras
et al., 1994). Detection of Foxa2mRNA also revealed that the ﬂoor plate
of the neural tube had been generated in the mutant embryos,
although the domain of Foxa2 expression appeared to be expanded
comparedwith controls. Finally, like control embryos,Gata4−/−Gata6−/−
embryos were found to generate blood vessels that expressed the
endothelial cell marker CD31 (Fig. 2c, PECAM). Together, these data
demonstrate that loss of both GATA4 and GATA6 has a relatively
speciﬁc effect on the development of the cardiogenic mesoderm and
does not cause a general deﬁciency in gastrulation or mesodermal
migration.
We next performed immunohistochemistry to detect markers of
cardiac myocytes to determine whether GATA4 and GATA6 were
Fig. 2. Loss of both GATA4 and GATA6 precludes development of the heart. (a) Distribution of Gata4 and Gata6 mRNAs detected in E7.5, early headfold stage, and E8.5, 6–8 somite
stage, embryos by in situ hybridization. (b) Micrograph showing typical E8.5 embryos generated from either control (G4+/+G6+/+) or GATA4/6 doubly null (G4−/−G6−/−) ES cells from
which the yolk sac has been removed. (c) Sections of control or GATA4/6 null embryos stained with hematoxylin and eosin (H&E), by immunohistochemistry for expression of FoxA1,
HNF4α, or Pecam (CD31), and by in situ hybridization for Foxa2mRNA. The presence of cardiac tissue in control embryos is indicated with an arrowhead, the expected location of the
heart inmutant embryoswith an arrow, and the anterior intestinal portal by an asterisk (*). c, cardiac crescent; 1°, presumptive primary heart ﬁeld; 2° presumptive second heart ﬁeld;
en, deﬁnitive endoderm; ht, primary heart tube; fp, neural tube ﬂoorplate; ec, endocardium; ExE, extra embryonic endoderm; v, blood vasculature. The positions of the proximal–
distal (prox–dist), anterior–posterior (A–P) and dorsal–ventral (D–V) axes are shown where appropriate.
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absence of the heart was primarily due to a block in morphogenesis of
differentiated cardiac cells. Fig. 3 shows that smooth muscle actin
(SMA), alpha myosin heavy chain (αMHC), and alpha cardiac actin (α-
sarcomeric actin) could be detected in the differentiating cardiac
myocytes forming the heart tube as well as in the yolk sacs of E8.5 (8–
12 somites) embryos derived from control ES cells. In contrast,
expression of these proteins was undetectable in Gata4−/−Gata6−/−
embryos, although staining was easily identiﬁable in the yolk sac (Fig.
3).We also examinedexpression of the co-activator Smarcd3 (encoding
Baf60c) as an example of a gene expressed in myocytes that is not a
structural component of myoﬁbrils. Smarcd3 mRNA was found to be
robustly expressed in the cardiac crescent in control embryos, as
described previously (Lickert et al., 2004), but was absent from the
corresponding region of Gata4−/−Gata6−/− (Fig. 3, Smarcd3). At about
E7.5 (early headfold), cardiac progenitors have formed the cardiac
crescent that overlays the anterior intestinal portal, and expression of
myocyte markers can ﬁrst be identiﬁed in a subset of cells within the
crescent that have committed to a cardiacmyocyte cell-fate (Olson and
Schneider, 2003). While we identiﬁed nascent cardiac myocytes in
control embryos using immunohistochemistry to detect smoothmuscle actin (Fig. 3, bottom panel, arrowhead), no smooth muscle
actin positive cells, outside of the yolk sac, could be detected in
Gata4−/−Gata6−/− embryos (Fig. 3, Sma).
Although transcription factors expressed in cardiac progenitor cells
could be detected inGata4−/−/Gata6−/− embryoid bodies, we considered
the possibility that the absence of differentiated cardiac myocytes
could result from a failure in formation of progenitor cells in vivo. We
therefore examined the expression of mRNAs encoding cardiac
progenitor cell markers Isl1, Nkx2.5, and Tbx5. Isl1 mRNA, which is
predominantly expressed in progenitors within the second heart ﬁeld
(Cai et al., 2003), could be detected in both control and mutant em-
bryos at both E8.5 and E7.5 (Fig. 4, Isl1). Similarly,Nkx2.5mRNA, which
is expressed in both primary and second heart ﬁelds, was also detected
in both control and mutant embryos at E8.5 (Fig. 4, Nkx2.5). Both Isl1
andNkx2.5mRNAwere found in tissue sections to bemost abundant in
two lateral domains of mesoderm that mark the cardiac progenitors
(Fig. 4). In contrast to those markers expressed in the second heart
ﬁeld, expression of Tbx5 mRNA, which is predominantly expressed in
the primary heart ﬁeld progenitor cells and was detectable in control
embryos, was undetectable in Gata4−/−Gata6−/− embryos (Fig. 4, Tbx5).
These data imply that while GATA4 and GATA6 act to control the onset
Fig. 3. Differentiated cardiac myocytes are undetectable in GATA4/GATA6 null embryos.
Micrographs showing control (G4+/+ G6+/+) and mutant (G4−/− G6−/−) whole embryos
or sections of embryos at E8.5 (8–10 somites) or E7.5 (1–2 somites) stained by
immunohistochemistry (brown staining) to reveal expression of smooth muscle actin
(SMA), myosin heavy chain (MHC), sarcomeric actin (αSrcAct), or by in situ
hybridization to identify Smarcd3 mRNA. Cardiac myocytes are indicated with an
arrowhead in control embryos and the expected position of such cells with an arrow in
mutant embryos. Anterior–posterior axis (A–P) and extra-embryonic endoderm (ExE) is
shown where appropriate.
Fig. 4. GATA4 and GATA6 are dispensable for formation of second heart ﬁeld cardiac
progenitor cells. Micrographs showing the expression of Isl1 in E8.5 (8–10 somites) and
E7.5 (early headfold) embryos, and Nkx2.5 and Tbx5 in E8.5 embryos (8–10 somites) by
in situ hybridization. Arrowheads and arrows show the presence of presumptive cardiac
progenitor cells in control and mutant embryos, respectively. Sections through Isl1 and
Nkx2.5-stained embryos conﬁrm the presence of these mRNAs in the mesoderm. All
panels show ventral views of embryos with the proximal–distal axis positioned from
top to bottom.
618 R. Zhao et al. / Developmental Biology 317 (2008) 614–619of cardiac myocyte differentiation they are dispensable for formation
of second heart ﬁeld progenitor cells.
Discussion
In summary, we conclude that GATA4 and GATA6 have overlapping
but essential roles in ensuring that progenitors follow a cardiac myo-
cyte cell fate during mammalian development. The mechanism
through which this occurs is likely to be complex, and clarity will re-
quire further study. However, our data demonstrate that, while
formation of the second heart ﬁeld progenitor cells and their anterior
migration to the cardiac crescent is independent of GATA4 or GATA6function, the differentiation of these progenitors into cardiacmyocytes
aswell as formation of the primary heartﬁeld progenitors is blocked by
the absence of both GATA4 and GATA6. Such a conclusion is also
supported by our analyses of cardiac myocyte differentiation from ES
cells in which expression of markers of cardiac myocytes and trans-
cription factors expressed in the primary heart ﬁeld are dramatically
619R. Zhao et al. / Developmental Biology 317 (2008) 614–619reduced in the absence of GATA4 and GATA6, whereas markers of the
second heart ﬁeld, such as Isl1, or early undeﬁned cardiac progenitor
cells, such as Mesp1 and Mesp2, are unaffected by loss of GATA4 and
GATA6. In addition to cardiac myocytes, GATA4 and GATA6 are both
expressed in the early deﬁnitive endoderm, and so the question of
whether the dependence on GATA4 and GATA6 for differentiation of
cardiac myocytes is strictly cell autonomous has yet to be resolved.
Based on the above analyses of Gata4−/−Gata6−/− embryos, we are
conﬁdent that the deﬁnitive endoderm is generated in the absence of
GATA4 and GATA6; however, we cannot deﬁnitively exclude the
possibility that deﬁciencies in endoderm morphogenesis or differ-
entiation contribute to the absence of cardiac myocytes in these
embryos. Aggregation chimeras generated between ROSA26 morulae
and Gata4−/−Gata6−/− ES cells did not answer this possibility because in
such chimeras both the endoderm and developing heart were popu-
lated bywild type cells (not shown). Nevertheless, a signiﬁcant body of
evidence supports the view that although the endoderm is required for
later myocardial contraction (Jacobson and Sater, 1988), it is dis-
pensable for the onset of cardiac myocyte differentiation. For example,
expression of cardiac differentiation markers in chick lateral plate
mesoderm occurs normally following the removal of the deﬁnitive
endoderm (Gannon and Bader, 1995), and Zebraﬁsh casanovamutants,
which suffer from a complete absence of deﬁnitive endoderm, exhibit
cardia biﬁda but still generate cardiac mycocytes (Alexander et al.,
1999). A cell autonomous role for GATA control of cardiac myocyte
differentiation is also supported by the observation that the GATA
factors, whose own expression responds to BMP signaling (Schultheiss
et al., 1997), can directly control transcription of genes encoding nu-
merous cardiac transcription factors and structural proteins, including
MEF2c (Dodou et al., 2004) and NKX2.5 (Reecy et al., 1999). Such
ﬁndings, alongwith our current analyses, support a model whereby, in
response to BMP signaling, the GATA factors act as a molecular lyn-
chpin to ensure robust expression of the network of transcription
factors that orchestrates expression of cardiac myocyte genes during
progenitor cell differentiation.
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